Matthews International Capital Management LLC Legend Biotech Corp Transaction History

Matthews International Capital Management LLC

$468 Million
Q4 2024

A detailed history of Matthews International Capital Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Matthews International Capital Management LLC holds 1,185,516 shares of LEGN stock, worth $45.2 Million. This represents 8.24% of its overall portfolio holdings.

Number of Shares

1,185,516

Previous 1,031,851 14.89%

Holding current value

$45.2 Million

Previous $50.3 Million 23.28%

% of portfolio

8.24%

Previous 8.53%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$32.49 - $50.28 $4.99 Million - $7.73 Million	153,665 Added 14.89%	1,185,516 $38.6 Million
Q3 2024 Oct 15, 2024	BUY	$43.55 - $59.88 $395,042 - $543,171	9,071 Added 0.89%	1,031,851 $50.3 Million
Q2 2024 Jul 22, 2024	BUY	$39.5 - $57.22 $10.7 Million - $15.5 Million	270,845 Added 36.02%	1,022,780 $45.3 Million
Q1 2024 Apr 15, 2024	SELL	$55.06 - $69.99 $3.17 Million - $4.03 Million	-57,639 Reduced 7.12%	751,935 $42.2 Million
Q4 2023 Jan 17, 2024	SELL	$57.25 - $69.74 $18 Million - $21.9 Million	-314,254 Reduced 27.96%	809,574 $48.7 Million
Q3 2023 Oct 27, 2023	BUY	$63.16 - $76.5 $8,589 - $10,404	136 Added 0.01%	1,123,828 $75.5 Million
Q2 2023 Aug 10, 2023	SELL	$46.28 - $75.01 $8.47 Million - $13.7 Million	-182,976 Reduced 14.0%	1,123,692 $77.6 Million
Q1 2023 May 10, 2023	BUY	$43.42 - $57.37 $5.86 Million - $7.74 Million	134,900 Added 11.51%	1,306,668 $63 Million
Q4 2022 Feb 09, 2023	SELL	$38.8 - $55.46 $11.4 Million - $16.3 Million	-294,685 Reduced 20.1%	1,171,768 $58.5 Million
Q3 2022 Nov 04, 2022	BUY	$38.15 - $57.1 $9.31 Million - $13.9 Million	244,111 Added 19.97%	1,466,453 $59.8 Million
Q2 2022 Jul 13, 2022	BUY	$33.54 - $55.0 $4.09 Million - $6.7 Million	121,800 Added 11.07%	1,222,342 $67.2 Million
Q1 2022 May 05, 2022	BUY	$31.02 - $48.18 $2.97 Million - $4.62 Million	95,800 Added 9.53%	1,100,542 $40 Million
Q4 2021 Feb 02, 2022	SELL	$41.14 - $56.98 $14.5 Million - $20 Million	-351,800 Reduced 25.93%	1,004,742 $46.8 Million
Q3 2021 Nov 08, 2021	BUY	$35.31 - $50.56 $497,871 - $712,896	14,100 Added 1.05%	1,356,542 $68.6 Million
Q2 2021 Aug 10, 2021	BUY	$25.8 - $41.09 $7.44 Million - $11.8 Million	288,200 Added 27.34%	1,342,442 $55.1 Million
Q1 2021 May 06, 2021	BUY	$23.55 - $32.4 $6.57 Million - $9.04 Million	279,000 Added 35.99%	1,054,242 $30.6 Million
Q4 2020 Feb 09, 2021	SELL	$25.8 - $32.39 $5 Million - $6.27 Million	-193,620 Reduced 19.98%	775,242 $21.8 Million
Q3 2020 Nov 05, 2020	SELL	$27.5 - $39.61 $6.31 Million - $9.1 Million	-229,621 Reduced 19.16%	968,862 $29.9 Million
Q2 2020 Jul 29, 2020	BUY	$36.1 - $42.56 $43.3 Million - $51 Million	1,198,483 New	1,198,483 $51 Million

Others Institutions Holding LEGN

# of Institutions

226

Shares Held

74.6M

Call Options Held

279K

Put Options Held

350K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.38B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account

Matthews International Capital Management LLC Legend Biotech Corp Transaction History